PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-60.59%
Negative revenue growth while Insurance - Life median is -2.71%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-60.59%
Negative gross profit growth while Insurance - Life median is -22.31%. Seth Klarman would suspect poor product pricing or inefficient production.
-7.96%
Negative EBIT growth while Insurance - Life median is -7.96%. Seth Klarman would check if external or internal factors caused the decline.
-9.74%
Negative operating income growth while Insurance - Life median is -18.27%. Seth Klarman would check if structural or cyclical issues are at play.
-12.96%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-13.79%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-13.79%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.31%
Maintaining or raising dividends while Insurance - Life median is negative. Peter Lynch might see a strong advantage in stable distributions.
-5.17%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-5.17%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-63.23%
Negative 10Y revenue/share CAGR while Insurance - Life median is -13.35%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
-45.85%
Negative 5Y CAGR while Insurance - Life median is -13.63%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-72.72%
Negative 3Y CAGR while Insurance - Life median is -35.64%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
193.94%
OCF/share CAGR of 193.94% while Insurance - Life median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
25.98%
5Y OCF/share growth near Insurance - Life median. Charlie Munger might attribute it to standard sector conditions for mid-term OCF expansions.
5.80%
3Y OCF/share growth of 5.80% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
140.71%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
57.92%
5Y net income/share CAGR 50-75% of Insurance - Life median. Guy Spier might question fundamental disadvantages in cost structure or growth drivers.
-16.54%
Negative 3Y CAGR while Insurance - Life median is 17.92%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
54.02%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 8.02% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
5.41%
Positive 5Y equity/share CAGR while Insurance - Life median is negative. Peter Lynch sees an advantage over struggling peers in capital accumulation.
-9.86%
Negative 3Y equity/share growth while Insurance - Life median is -26.24%. Seth Klarman sees a short-term weakness if peers still expand net worth.
152.05%
Dividend/share CAGR exceeding 1.5x Insurance - Life median of 61.10% over 10 years. Joel Greenblatt sees a standout distribution growth track, assuming sustainability.
121.94%
5Y dividend/share CAGR > 1.5x Insurance - Life median of 31.38%. Joel Greenblatt would see if strong mid-term fundamentals back these hikes.
11.44%
3Y dividend/share growth 50-75% of Insurance - Life median. Guy Spier suspects the firm lags in near-term shareholder returns vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.75%
Asset growth of 2.75% while Insurance - Life median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
2.56%
Positive BV/share change while Insurance - Life median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
7.10%
Debt growth of 7.10% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
10.30%
SG&A growth of 10.30% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.